List of Excipients in API glyburide-metformin hydrochloride
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing glyburide-metformin hydrochloride
Detailed excipient profiles for glyburide-metformin hydrochloride
Excipient focus: D&C YELLOW NO. 10
glyburide-metformin hydrochloride drug variants containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Preferred Pharmaceuticals Inc | glyburide-metformin hydrochloride | 68788-8791 |
| Bryant Ranch Prepack | glyburide-metformin hydrochloride | 71335-2508 |
| >Company | >Ingredient | >NDC |
glyburide-metformin hydrochloride drug variants not containing D&C YELLOW NO. 10
Excipient focus: FERRIC OXIDE RED
glyburide-metformin hydrochloride drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Blenheim Pharmacal Inc | glyburide-metformin hydrochloride | 10544-580 |
| Bryant Ranch Prepack | glyburide-metformin hydrochloride | 71335-2694 |
| >Company | >Ingredient | >NDC |
glyburide-metformin hydrochloride drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
glyburide-metformin hydrochloride drug variants containing FERRIC OXIDE YELLOW
glyburide-metformin hydrochloride drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
glyburide-metformin hydrochloride drug variants containing HYPROMELLOSE 2910
glyburide-metformin hydrochloride drug variants not containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: KI203
glyburide-metformin hydrochloride drug variants containing KI203
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | glyburide-metformin hydrochloride | 50090-7514 |
| >Company | >Ingredient | >NDC |
glyburide-metformin hydrochloride drug variants not containing KI203
Excipient focus: MAGNESIUM STEARATE
glyburide-metformin hydrochloride drug variants containing MAGNESIUM STEARATE
glyburide-metformin hydrochloride drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PEG-135
glyburide-metformin hydrochloride drug variants containing PEG-135
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | glyburide-metformin hydrochloride | 50090-7514 |
| >Company | >Ingredient | >NDC |
glyburide-metformin hydrochloride drug variants not containing PEG-135
Excipient focus: POLYETHYLENE GLYCOL 6000
glyburide-metformin hydrochloride drug variants containing POLYETHYLENE GLYCOL 6000
glyburide-metformin hydrochloride drug variants not containing POLYETHYLENE GLYCOL 6000
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | glyburide-metformin hydrochloride | 50090-7514 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
glyburide-metformin hydrochloride drug variants containing POVIDONE
glyburide-metformin hydrochloride drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
glyburide-metformin hydrochloride drug variants containing PROPYLENE GLYCOL
glyburide-metformin hydrochloride drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SAND
glyburide-metformin hydrochloride drug variants containing SAND
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | glyburide-metformin hydrochloride | 50090-7514 |
| >Company | >Ingredient | >NDC |
glyburide-metformin hydrochloride drug variants not containing SAND
Excipient focus: SILICON DIOXIDE
glyburide-metformin hydrochloride drug variants containing SILICON DIOXIDE
glyburide-metformin hydrochloride drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | glyburide-metformin hydrochloride | 50090-7514 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
glyburide-metformin hydrochloride drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
glyburide-metformin hydrochloride drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
glyburide-metformin hydrochloride drug variants containing TALC
glyburide-metformin hydrochloride drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
glyburide-metformin hydrochloride drug variants containing TITANIUM DIOXIDE
glyburide-metformin hydrochloride drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch